Boston Scientific BSX
-
Feeling A Little Better About The Growth/Value Proposition At Medtronic
By Stephen Simpson : Med-tech isn't much different than any other sector of the market; when the growth goes, so do the investors. While the widespread slowdowns in multiple key businesses have definitely dented Medtronic's ( MDT ) recent growth, it's not as though the stock may seem to be an ...
-
VHT Vanguard Health Care ETF ETF Analysis, Report, Research, 5 Star Rating – Morningstar
… Think of the challenges raised (and wealth destroyed) with Wyeth's Fen-phen, Merck's MRK Vioxx, or Boston Scientific 's BSX drug-eluting stents. A product can be wildly successful one year and spawn thousands of lawsuits the next …
-
Catalysts That Could See Medtronic Jump After Earnings
By Investment Underground : By Doug Ehrman Medtronic Inc. ( MDT ) is scheduled to release earnings on May 22, 2012, and ahead of that announcement, the company is looking strong. Given the relative position of the company amongst its peers, there are viable alternatives for every level of risk ...
-
Earnings Preview: Medtronic
By Vytautas Drumelis : Medtronic, Inc. ( MDT ) manufactures and sells device-based medical therapies worldwide. It provides implantable cardioverter-defibrillators, cardiac resynchronization therapy devices, and cardiac pacemakers for the diagnosis, treatment, and management of heart rhythm ...
-
7 Rallying Healthcare Stocks Being Sold Off By Hedge Funds
By Kapitall : Do you follow the buying and selling trends of smart money investors? For a closer look at stocks currently out of favor with smart money institutional investors, we ran a screen. We began by screening the healthcare sector for stocks with positive market sentiment, rallying above ...
-
Update: Bullish Case For Boston Scientific
… April 30th, I detailed out my Bullish Case for Boston Scientific ( BSX ), on May 8th, BSX announced FDA approval of their new pacemaker line-up. Update To varying degrees, BSX has been hindered in the pacemaker market for …
-
UPDATE 1-Cameron Health's under-skin ICD safe, effective
May 10 (Reuters) - Cameron Health Inc, which agreed in March to be acquired by Boston Scientific Corp , said on Thursday its implantable heart defibrillator proved safe and effective for treating patients at risk for sudden cardiac arrest in a 330-patient clinical trial.
-
Cameron Health, which is being acquired by Boston Scientific ( BSX ), says its implantable heart defibrillator was safe and effective in a trial of 330 patients. The device is the first of its kind not ...
Cameron Health, which is being acquired by Boston Scientific ( BSX ), says its implantable heart defibrillator was safe and effective in a trial of 330 patients. The device is the first of its …
-
Cameron Health's under-skin defibrillator safe, effective
May 10 (Reuters) - Cameron Health Inc, which agreed in March to be acquired by Boston Scientific Corp , said on Thursday it s implantable heart defibrillator proved safe and effective for treating patients at risk for sudden cardiac arrest in a 330-patient clinical trial.
-
Abbott: New Reasons The Split Could Tank Stock
By Dividend Kings : Abbott Laboratories ( ABT ) has announced that it will split in two by the end of 2012. One half will be a diversified medical products company, while the other will be a research-based pharmaceutical companies. Are the two halves worth more than the whole to investors? And if